NCT04486859View on ClinicalTrials.gov

Postoperative Thrombosis Prevention in Patients With CD

NAActive, not recruitingINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 1, 2025

Study Completion Date

July 1, 2025

Conditions
Cushing DiseaseDVTPulmonary Embolism
Interventions
DRUG

LMWH/Rivaroxaban

combined prevention

DEVICE

IPC

mechanical prevention

Trial Locations (7)

200040

Huashan Hospital, Shanghai

350004

The First Affiliated Hospital of Fujian Medical University, Fuzhou

430000

Tongji Hospital, Wuhan

510000

The First Affiliated Hospital of Sun Yat sen University, Guangzhou

610041

China West Hospital, Chengdu

830001

People's Hopital of Xinjiang Uygur Autonomous Region, Ürümqi

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Huashan Hospital

OTHER